<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>We examined whether gamma-interferon (gamma-IFN) can be detected in serum and CSF of patients with multiple <z:mp ids='MP_0000612'>sclerosis</z:mp> and other inflammatory <z:e sem="disease" ids="C0027765" disease_type="Disease or Syndrome" abbrv="">neurological diseases</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain>Gamma-IFN was assayed by solid phase radioimmunoassay on the forward sandwich principle </plain></SENT>
<SENT sid="2" pm="."><plain>In 7 serum samples in <z:hpo ids='HP_0011009'>acute</z:hpo> stage of multiple <z:mp ids='MP_0000612'>sclerosis</z:mp> without <z:chebi fb="0" ids="50858">corticosteroid</z:chebi>, in 2 CSF samples in <z:hpo ids='HP_0011009'>acute</z:hpo> stage, gamma-IFN was not detected </plain></SENT>
<SENT sid="3" pm="."><plain>In stable stage there was no case with positive gamma-IFN </plain></SENT>
<SENT sid="4" pm="."><plain>The patient with <z:e sem="disease" ids="C0041296" disease_type="Disease or Syndrome" abbrv="tb|tbc">tuberculous</z:e> <z:hpo ids='HP_0001287'>meningitis</z:hpo> showed high titer in CSF but not in serum </plain></SENT>
<SENT sid="5" pm="."><plain>One case with <z:e sem="disease" ids="C0019360" disease_type="Disease or Syndrome" abbrv="ZONA">herpes zoster</z:e> <z:hpo ids='HP_0001287'>meningitis</z:hpo>, one case out of 2 aseptic <z:hpo ids='HP_0002383'>encephalitis</z:hpo> showed positive gamma-IFN in CSF </plain></SENT>
<SENT sid="6" pm="."><plain>In one case with <z:e sem="disease" ids="C0042170" disease_type="Disease or Syndrome" abbrv="">Vogt-Koyanagi-Harada disease</z:e>, gamma-IFN was detected both in serum and CSF </plain></SENT>
<SENT sid="7" pm="."><plain>One case with Neuro-<z:chebi fb="6" ids="22696">Beh</z:chebi>çet syndrome showed positive gamma-IFN in CSF </plain></SENT>
<SENT sid="8" pm="."><plain>No gamma-IFN was detected in 2 cases with <z:e sem="disease" ids="C0018378" disease_type="Disease or Syndrome" abbrv="">Guillain-Barré syndrome</z:e>, one case with <z:e sem="disease" ids="C0085404" disease_type="Disease or Syndrome" abbrv="">Crow-Fukase syndrome</z:e>, <z:e sem="disease" ids="C0393799" disease_type="Disease or Syndrome" abbrv="">Fisher syndrome</z:e>, 2 cases with polymyosits </plain></SENT>
<SENT sid="9" pm="."><plain>gamma-IFN in CSF was detected in <z:hpo ids='HP_0001287'>meningitis</z:hpo> and <z:hpo ids='HP_0002383'>encephalitis</z:hpo>, but not in serum </plain></SENT>
<SENT sid="10" pm="."><plain>This suggests that the locally infiltrating cells produce gamma-IFN </plain></SENT>
<SENT sid="11" pm="."><plain>However, we could not detect gamma-IFN in either CSF or serum of patients with multiple <z:mp ids='MP_0000612'>sclerosis</z:mp> </plain></SENT>
<SENT sid="12" pm="."><plain>Negative results of gamma-IFN in patients with multiple <z:mp ids='MP_0000612'>sclerosis</z:mp> can be interpreted in 2 ways </plain></SENT>
<SENT sid="13" pm="."><plain>1 </plain></SENT>
<SENT sid="14" pm="."><plain>The half life of gamma-IFN is very short in vivo, and the level of gamma-IFN may not be detected at the time of sampling </plain></SENT>
<SENT sid="15" pm="."><plain>2 </plain></SENT>
<SENT sid="16" pm="."><plain>Generalized augmentation of gamma-IFN production may not be observed but locally infiltrating cells or astrocytes might produce gamma-IFN.(ABSTRACT TRUNCATED AT 250 WORDS) </plain></SENT>
</text></document>